Item 5.07. Submission of Matters to a Vote of Security Holders.
At Cyclerion Therapeutics, Inc.'s (the "Company") annual meeting of stockholders
held on June 24, 2021, as contemplated by the Company's definitive proxy
material for the meeting, certain matters were submitted to a vote of
stockholders. The following tables summarize the results of voting with respect
to each matter:
1. Election of Directors:
Broker
For Against Withheld Non-Votes
Kevin Churchwell, M.D. 20,034,155 0 57,455 4,025,472
George Conrades 20,011,263 0 80,347 4,025,472
Errol De Souza, Ph.D. 19,388,700 0 702,910 4,025,472
Marsha Fanucci 19,598,737 0 492,873 4,025,472
Peter M. Hecht, Ph.D. 19,948,022 0 143,588 4,025,472
Ole Isacson, M.D., Ph.D. 20,033,506 0 58,104 4,025,472
Stephanie Lovell 20,064,598 0 27,012 4,025,472
Terrance McGuire 20,000,066 0 91,544 4,025,472
Michael Mendelsohn, M.D. 20,038,610 0 53,000 4,025,472
2. Ratification of the appointment of Ernst & Young LLP as the Company's
independent registered public accounting firm for the fiscal year ending
December 31, 2021:
For Against Abstain
23,981,513 132,953 2,616
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses